Arrowgrass Capital Partners (US)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-37,873
Closed -$5.72M 165
2018
Q1
$5.72M Sell
37,873
-81,929
-68% -$12.4M 0.2% 63
2017
Q4
$16.1M Sell
119,802
-27,922
-19% -$3.76M 0.16% 61
2017
Q3
$21.6M Buy
147,724
+36,816
+33% +$5.38M 0.16% 60
2017
Q2
$17.2M Buy
110,908
+54,286
+96% +$8.44M 0.13% 81
2017
Q1
$8.22M Buy
+56,622
New +$8.22M 0.08% 124
2016
Q4
Sell
-65,648
Closed -$7.98M 250
2016
Q3
$7.98M Sell
65,648
-44,455
-40% -$5.4M 0.11% 74
2016
Q2
$15.6M Buy
110,103
+32,683
+42% +$4.62M 0.17% 43
2016
Q1
$10.1M Sell
77,420
-33,546
-30% -$4.38M 0.12% 60
2015
Q4
$15.6M Buy
110,966
+2,944
+3% +$414K 0.19% 47
2015
Q3
$14.3M Sell
108,022
-13,169
-11% -$1.75M 0.27% 40
2015
Q2
$21.3M Buy
121,191
+11,309
+10% +$1.99M 0.32% 36
2015
Q1
$19M Buy
109,882
+48,621
+79% +$8.4M 0.29% 40
2014
Q4
$10M Buy
+61,261
New +$10M 0.18% 61